Common Benefit Fee

A common benefit fee is the compensation paid to PSC attorneys from the common benefit fund in recognition of legal work that created value for all plaintiffs on the docket, regardless of which firm retained each individual client. Courts apply a lodestar or percentage analysis to determine appropriate common benefit awards, with successful MDLs generating common benefit fees in the hundreds of millions of dollars on large pharmaceutical or product liability dockets. Litigation funders targeting PSC-level investments price their capital against expected common benefit fee flows, which are generally senior in priority and more predictable than individual claim recoveries. The risk in common benefit fee financing is primarily execution risk — PSC firms must actually perform the work, survive Daubert challenges, and drive the docket to resolution before fee entitlements vest.

Because common benefit fees are generally senior and more predictable than individual claim recoveries, funders targeting PSC-level investments price capital against expected fee flows using the docket's stage and settlement trajectory, not against any single client's claim value. The principal risk in this structure is execution, not merits — PSC firms must actually perform the common work and survive Daubert challenges before fee entitlements vest, which is why funders diligence firm capacity and track record as heavily as the underlying science.